icon3

Life Science Instrumentation Market By Technology(Chromatography, Electrophoresis & Others) By Application (Clinical and diagnostic applications, Research applications, Others) By End-User (Hospitals, Pharmaceutical, and bio companies, Others) Regional Analysis & Forecast - 2026

  • OI-116
  • |
  • Published date: May, 2019
  • |
  • Life Sciences & Healthcare
  • |
  • 0 Pages

Introduction


Life science instruments are mainly utilized in analytical procedures and method validation for drugs and biologics throughout drug discovery. The ongoing development of new technologies in life science instrumentation, for example, ultra-high-resolution analytical instruments, and next-generation sequencing are probably to expand the pace of drug development. Most significant analytical instrument manufacturers are concentrating on the development of miniaturized instruments, which is the key trend observed in the global market. Significant biotech companies are contributing more on the enhancement and growth of the vital need for life science innovations.


Market Overview


The global Life Science Instrumentation market was valued at $XX Bn in 2018 and is forecast to grow at a strong XX% CAGR between 2018 and 2026, resulting in 2026 global sales of $XX Bn driven by owing to the Technological advancements in analytical instruments and rising expenditure on Pharmaceutical R&D. However, Lack of Skilled Personnel and the high price of instruments are restraining the market growth. One of the major opportunities for market growth is the growing demand for analytical instruments in proteomics.


Life Science Instrumentation Market by technology, spectroscopy segment is predictable to account for the largest market share owing to the widespread application of spectroscopy systems across several industries, including pharmaceutical, biopharmaceutical, food and agriculture, and environmental testing.


Life Science Instrumentation Market depending on end user, the Pharmaceutical and bio companies segment can be attributed to the Increasing food and environmental safety concerns, obtainability of research funding for academic institutions, growing number of criminal cases, increasing number of drug discovery and development related research studies, and growing incidence of target diseases and testing procedures associated to them are pushing the demand among end users.


Key Developments



  • In February 2018, Bruker Corporation acquired IRM2, a developer of high-speed infrared (IR) imaging microscopes based on quantum cascade laser (QCL) technology.



  • In June 2017, Bio-Rad Laboratories, Inc. announced the launch of CFX Maestro Software for CFX Real-Time Instruments, a complete workflow solution for real-time PCR data collection and analysis.


Segmentation


The global Life Science Instrumentation market is segmented on the basis of technology type, Application, end-user, and region.


Based on the Technology Type: Chromatography, Electrophoresis, Liquid handling, Centrifuges, Flow cytometry, and Others.


Based on the Application: Clinical and diagnostic applications, Research applications, Forensic applications, Petrochemical industry, Food and beverage testing, Environmental testing, Industrial chemistry, Cosmetic industry, and Other Applications.


Based on the End User: Hospitals, Pharmaceutical and bio companies, Research Institutions, Laboratories, and Other End Users.


Based on the region: North America, Asia-Pacific, Europe, and LAMEA. Among that, North America is predictable to dominate the market in the upcoming future owing to the occurrence of a large customer base, and availability of funds for drug discovery processes and life science research studies in this region. The U.S. contributed the largest revenue to the North American as well as global life science instrumentation market.


The key players of the Global Life Science Instrumentation market include Perkinelmer, Inc, Danaher Corporation, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, Siemens Healthcare Diagnostics, Abbott Laboratories, Shimadzu Corporation, Bruker Corporation, Waters Corporation, Horiba Ltd., GE Healthcare, Eppendorf AG, Merck KGaA, Qiagen N.V. and Hitachi High-Technologies Corporation. and Others

The report covers in-depth analysis of Global Life Science Instrumentation Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by application (Clinical and diagnostic applications, Research applications, Forensic applications, Food and beverage testing, Cosmetic industry, and Others). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations


The report includes in-depth company profiles of key players in the Global Life Science Instrumentation Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments


The report highlights information on emerging companies with potentially disruptive technologies and new market entrants


Scope:



  • Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Life Science Instrumentation Market.

  • Provides a comparative analysis of key marketed products and pipeline market products.

  • Provides key information on players involved in the Global Life Science Instrumentation Market.

  • Provides a complete overview of market segments and the regional outlook of Global Life Science Instrumentation Market.

  • Provides in-depth coverage of key news related to global Life Science Instrumentation Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates



 

 

 

Our research works on a holistic 360° approach to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involve the following steps:




  • Data Collation (Primary & Secondary)




  • In-house Estimation (Based on proprietary databases and Models)




  • Market Triangulation




  • Forecasting




  • Market-related information is assembled from both primary and secondary sources.








  • Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services. 








  • Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others. 







  • Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.



REPORT YOU MIGHT BE INTERESTED

Choose Licence Type

$3,850.00
$4,950.00


(For Corporate Licence Only) Complementary
Credit card Logo
Inquiry Before Buying

Related Reports


Contact Us

Email Us at: sales@optimainsights.org | Reach Us at: +91 966 6620 365 | +1 424 2554 365 (US)